According to IMARC Group’s latest report, titled “Breast Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global breast imaging market reached a value of US$ 3.70 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.70% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Breast imaging refers to the technique of diagnosing breast cancer through high-resolution images of breast tissues in both males and females. It involves numerous ionizing and non-ionizing technologies to screen, detect, and diagnose the type of cancer, its location, and stage of progression. It also utilizes various imaging procedures, such as screening mammography and breast ultrasound, to check for suspicious tissues and the surrounding auxiliary tissues for the early diagnosis of cancer before the actual symptoms appear.
Request Free Report Sample: https://www.imarcgroup.com/breast-imaging-market/requestsample
The growing incidences of breast cancer are primarily driving the global breast imaging market. Besides this, the increasing awareness regarding the early detection of breast cancer and related diseases is also contributing to the market growth. Furthermore, the World Health Organization (WHO) has identified breast cancer as one of the most prevalent forms of cancer among women. As a result, governments worldwide are taking initiatives and preventive measures to mitigate the risk factors and enhance cancer screening and diagnosis. For instance, the Government of the United Kingdom has launched the “Be clear on cancer” program, which focuses on the early diagnosis of cancer. This has led to a significant rise in the adoption rate of breast imaging procedures across the globe. Moreover, extensive investments in advanced imaging software and hybrid systems, such as automated whole breast ultrasound systems (AWBU) and MBI/BSGI, are also facilitating market growth.
Breast Imaging Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global breast imaging market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Dilon Technologies Inc.
Siemens Healthineers AG (Cerner Corporation)
Allengers Medical Systems Limited
Delphinus Medical Technologies
Koninklijke Philips N.V.
Carestream Health Inc. (Onex Corporation)
Aurora Health Care Inc. (Schoen Clinic)
Key Market Segmentation:
The report has segmented the global breast imaging market on the basis of technology, end user and region.
Breakup by Technology:
Ionizing Breast Imaging
Positron Emission Tomography-Computed Tomography
Molecular Breast Imaging
Positron Emission Mammography
Cone-Beam Computed Tomography
Non-Ionizing Breast Imaging
Automated Whole-Breast Ultrasound
Electric Impedance Tomography
Breakup by End-User:
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Breakup by Region:
Middle East and Africa
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/breast-imaging-market
Key Highlights of the Report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Market Drivers and Success Factors
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800